BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 23, 2007
View Archived Issues
TMC-435350 safe in phase I trial in heathy volunteers
Read More
MQX-503 reduces the severity of Raynaud's phenomenon in clinical studies
Read More
Glycine, D-cycloserine ineffective in CONSIST schizophrenia trial
Read More
Efficacy similar with naproxcinod and naproxen in osteoarthritis patients
Read More
Niacin/laropiprant combined with simvastatin improves dyslipidemia
Read More
Risperidone beneficial in refractory major depressive disorder
Read More
Inhibitex obtains license for HCV polymerase inhibitors from U.K. and Belgian universities
Read More
Bone Medical initiates phase I/II clinical trial of oral CaPTHymone for osteoporosis
Read More
Cytos Biotechnology reports positive results from three phase IIa clinical trials of CYT004-MelQbG10
Read More
Novo Nordisk reports positive results from phase II study of liraglutide for obesity
Read More
Recent GSK patent discloses new antiinfective agents
Read More
New treatments for metabolic disorders reported in recent IRM and Schering patents
Read More
Recent patents describe novel agents for psychiatric disorders
Read More
Meyer obtains license from AnGes for NF-kappaB decoy for inflammatory disease
Read More
Merck & Co. suspends enrollment in clinical trials of kinase inhibitor MK-0457
Read More
EMEA recommends suspension of marketing authorization of medicines containing aprotinin
Read More
Cardiome initiates phase I study of GED-aPC
Read More
Avexa initiates two phase III clinical trials of apricitabine for drug-resistant HIV
Read More
Chinese Food and Drug Administration approves GNI's NDA for F-351
Read More
Arpida reports positive results from phase I trial of intravenous iclaprim
Read More
Hana initiates phase II clinical trial of Marqibo for metastatic malignant uveal melanoma
Read More
Medivir initiates TMC-435350-C201 phase IIa study of protease inhibitor TMC-435350
Read More
GlaxoSmithKline acquires Reliant Pharmaceuticals for USD 1.65 billion
Read More
Coley Pharmaceutical patents novel cytokine production promoters
Read More